Related Experiment Video

Updated: May 26, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Partners in crime: the TGFβ and MAPK pathways in cancer progression

Douglas A Chapnick1, Lisa Warner, Jennifer Bernet

  • 1Department of Chemistry and Biochemistry and Molecular, Cellular and Developmental Biology. Xuedong.Liu@Colorado.edu.

Cell & Bioscience
|December 30, 2011
PubMed

Insights

Transforming growth factor beta (TGFβ) and Ras-mitogen-activated protein kinase (Ras-MAPK) pathways oppose each other in normal cells but cooperate in cancers. This review explores their dual roles and potential therapeutic targets in tumor progression.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Molecular Signaling

Background:

  • The Transforming Growth Factor beta (TGFβ) pathway typically maintains cell differentiation and suppresses proliferation.
  • The Ras-MAPK pathway promotes cell proliferation, survival, and differentiation.
  • These pathways normally act antagonistically in cellular development and regulation.

Purpose of the Study:

  • To elucidate the distinct roles of TGFβ and Ras-MAPK pathways in normal cellular states.
  • To explain the mechanism by which simultaneous activation of these pathways drives cancer progression and metastasis.
  • To identify potential therapeutic targets within these signaling cascades.

Main Methods:

  • Literature review and synthesis of existing research on TGFβ and Ras-MAPK signaling.
  • Analysis of pathway interactions in normal versus malignant cellular contexts.
  • Identification and discussion of therapeutic strategies targeting these pathways.

Main Results:

  • TGFβ and Ras-MAPK pathways are critical regulators of cell development, cell cycle, tumor formation, and metastasis.
  • In normal cells, TGFβ suppresses proliferation while Ras-MAPK promotes it, creating an antagonistic relationship.
  • Simultaneous activation of both pathways is observed in colorectal and pancreatic cancers, driving tumor progression.

Conclusions:

  • The aberrant, concomitant activation of TGFβ and Ras-MAPK pathways is a key mechanism promoting cancer progression and metastasis.
  • Understanding these interactions is crucial for developing effective cancer therapies.
  • Targeting specific components of these pathways offers promising therapeutic avenues for cancer treatment.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...